Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the tolerability, acceptability and potential effect size of the efficacy of 4
months of atomoxetine treatment for patients with co-occurring ATS and heroin dependence
(COATS) receiving buprenorphine maintenance treatment (BMT) and educational drug and HIV risk
reduction counseling (EDRC).